Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
FDA OKs Zolbetuximab for Gastric, Gastroesophageal Cancer
The US Food and Drug Administration (FDA) has approved zolbetuximab (Vyloy, Astellas Pharma) in combination with fluoropyrimidine and platinum-containing chemotherapy for the first-line treatment of locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma that is claudin 18.2…
English